Document is current
Any future updates will be listed below
-
Authors
Lau, Loretta M. S. https://orcid.org/0000-0002-3172-0970
Khuong-Quang, Dong-Anh https://orcid.org/0000-0001-6305-7790
Mayoh, Chelsea https://orcid.org/0000-0002-6398-3046
Wong, Marie https://orcid.org/0000-0003-0066-6606
Barahona, Paulette
Ajuyah, Pamela
Senapati, Akanksha
Nagabushan, Sumanth https://orcid.org/0000-0001-7574-8919
Sherstyuk, Alexandra
Altekoester, Ann-Kristin
Fuentes-Bolanos, Noemi A.
Yeung, Veronica https://orcid.org/0000-0003-4765-4303
Sullivan, Ashleigh
Omer, Natacha https://orcid.org/0000-0002-5643-1307
Diamond, Yonatan
Jessop, Sophie
Battaglia, Lauren
Zhukova, Nataliya https://orcid.org/0000-0002-3221-2396
Cui, Louise https://orcid.org/0000-0003-4762-3099
Lin, Angela https://orcid.org/0000-0002-2637-3070
Gifford, Andrew J.
Fleuren, Emmy D. G.
Dalla-Pozza, Luciano
Moore, Andrew S. https://orcid.org/0000-0001-8062-1779
Khaw, Seong-Lin
Eisenstat, David D. https://orcid.org/0000-0002-5976-0798
Gottardo, Nicholas G. https://orcid.org/0000-0002-1082-6776
Wood, Paul J.
Tapp, Heather
Alvaro, Frank
McCowage, Geoffrey
Nicholls, Wayne https://orcid.org/0000-0003-0926-526X
Hansford, Jordan R. https://orcid.org/0000-0001-7733-383X
Manoharan, Neevika
Kotecha, Rishi S. https://orcid.org/0000-0003-1836-4075
Mateos, Marion K. https://orcid.org/0000-0002-2763-5853
Lock, Richard B.
Tyrrell, Vanessa https://orcid.org/0000-0002-5162-517X
Haber, Michelle https://orcid.org/0000-0003-2036-8817
Trahair, Toby N. https://orcid.org/0000-0002-3295-228X
Cowley, Mark J. https://orcid.org/0000-0002-9519-5714
Ekert, Paul G. https://orcid.org/0000-0002-2976-8617
Marshall, Glenn M.
Ziegler, David S. https://orcid.org/0000-0001-7451-7916
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (APP2019056, APP2017898, APP2018642, APP1157871, APP2018642, APP2018642)
Cancer Institute NSW (2021/TPG2112, 2020/ECF1261, ECF181430, 2021/TPG2112, 2021/TPG2112)
- License Information
-
More Information
Article History
Received: 21 September 2023
Accepted: 6 May 2024
First Online: 6 June 2024
Competing interests
: All authors, except P.G.E., S.-L.K., L.M.S.L., J.R.H., N.G.G. and D.S.Z., declare no competing interests. L.M.S.L. received consulting and advisory board fees from Bayer; J.R.H. received fees from Bayer, AstraZeneca/Alexion and Boxer Capital; N.G.G received fees to his institution from Bayer and Day One; D.S.Z. received fees from Bayer, AstraZeneca/Alexion, Accendatech, Novartis, Day One, FivePhusion, Amgen and Norgine, and research support from Accendatech. P.G.E. and S.-L.K. are recipients of a share in milestone and royalty payments for venetoclax development.
